CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

David Briskey

ORCID: 0000-0001-9867-6700↗

Public evidence

2 connected articles

The Effect of Levagen+ (Palmitoylethanolamide) Supplementation on Symptoms of Allergic Rhinitis-A Double-Blind Placebo-Controlled Trial.2023 · Europe PMC Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study.2021 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 08/09/2026.

David Briskey - Medical Cannabis Research Engine